Advanced Search

Journal of Traditional Chinese Medicine >

2024 , Vol. 44 >Issue 2: 381 - 387

DOI: https://doi.org/10.19852/j.cnki.jtcm.2024.02.003

Effectiveness and safety of Qidong Huoxue decoction (芪冬活血饮) in treatment of acute lung injury and acute respiratory distress syndrome: a randomized, controlled trial

  • Zhengqiu YU ,
  • Liuda YU ,
  • Ye CHEN ,
  • Mingjing LI ,
  • Wanru CAI
Expand
  • 1 School of Medicine, Xiamen University, Xiamen 361005, China
    2 the Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China
    3 Department of Respiratory Medical, the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China
    4 Department of Respiratory Medical, the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China

Received date: 2022-12-11

  Accepted date: 2023-04-19

  Online published: 2024-03-05

Supported by

Zhejiang Province Traditional Chinese Medicine Science and Technology Plan: the Study on Clinical Effects of Qidong Huoxue decoction in the Treatment of Acute Lung Injury(2017ZZ008)

Fold

Abstract

OBJECTIVE: To evaluate the efficacy of Qidong Huoxue decoction (芪冬活血饮，QDHX) in treating acute lung injury and acute respiratory distress syndrome (ALI/ARDS) when used as an adjunctive treatment.

METHODS: ALI/ARDS patients admitted to our medical intensive care unit were randomly allocated to the control group or the QDHX group and received standard therapy. The QDHX group received QDHX (50 mL per day for 14 d) orally or via a gastric tube. The primary outcome was measured according to Traditional Chinese Medicine (TCM) syndrome scores, with partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) levels as the secondary outcome.

RESULTS: A total of 73 patients completed the study (36 in the TCM and 37 in the conventional group), and their records were analyzed. After 14-d treatment, the TCM group showed a significant decrease in TCM syndrome scores (P < 0.05) and increased PaO2/FiO2 levels (P < 0.05). The therapeutic effect of integrated Chinese and western medicine was more significant than that of Western Medicine alone. No serious side effects were observed.

CONCLUSIONS: Our study results show that QDHX in combination with conventional drug therapy can significantly reduce some clinical symptoms in patients with ALI/ARDS.

Key words： acute lung injury; respiratory distress syndrome; Qidong Huoxue decoction; randomized controlled trial

Cite this article

Zhengqiu YU , Liuda YU , Ye CHEN , Mingjing LI , Wanru CAI . Effectiveness and safety of Qidong Huoxue decoction (芪冬活血饮) in treatment of acute lung injury and acute respiratory distress syndrome: a randomized, controlled trial[J]. Journal of Traditional Chinese Medicine, 2024 , 44(2) : 381 -387 . DOI: 10.19852/j.cnki.jtcm.2024.02.003

References

1. Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet 2021; 398: 622-37.
2. Force ADT, Ranieri V, Rubenfeld G, et al. Acute respiratory distress syndrome. JAMA 2012; 307: 2526-33.
3. Griffiths MJ, McAuley DF, Perkins GD, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res 2019; 6: e000420.
4. Chao J, Dai Y, Verpoorte R, et al. Major achievements of evidence-based Traditional Chinese Medicine in treating major diseases. Biochem Pharmacol 2017; 139: 94-104.
5. Luo CY, Wang S, Li Y. In sight into diagnosis and treatment of acute resoiratory distress syndrome from the perspective of toxin, stasis and deficiency. J Tradit Chin Med 2017; 26: 823-6.
6. Liu Z, Li S, Zhao W, Zhou G. A systematic review and Meta-analysis of effect evaluation of Traditional Chinese Medicine in treating acute respiratory distress syndrome. Ann Palliat Med 2021; 10: 5520-32.
7. Huang L, Zhang X, Ma X, et al. Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS. Int Immunopharmacol 2018; 65: 96-107.
8. Cheng L, Zhang Y, He S, et al. A systematic review and Meta-analysis of Tongfu Xiefei method in the treatment of acute respiratory distress syndrome. Zhong Guo Wei Zhong Bing Ji Jiu Yi Xue 2020; 32:970-5.
9. Yang TZ, Liu Y, Liu YY, et al. The use of Rheum Palmatum L. in the treatment of acute respiratory distress syndrome: a Meta-analysis of randomized, controlled trials. Afr J Tradit Complem 2017; 14: 334-47.
10. Xu LY, Cai WR, Ma CF, Shou QY, Qian JL, Huseyin TS. Qi-Dong-Huo-Xue-Yin inhibits inflammation in acute lung injury in mice via toll-like receptor 4/caveolin-1 signaling. Evid-Based Compl Alt 2018; 2018: 2373609.
11. Hong HH, Yang JC, Cai WR. Effects of qidong huoxue decoction on caveolin-1/NF-κB inflammation signal pathway in acute lung injury rats. Zhong Hua Zhong Yi Yao Za Zhi 2016; 31: 239-43.
12. Cai WR, Hong HH, Lu XF. Effect of Qidong Huoxue decoction on rats’ ET-1 with acute lung injury caused by oleic acid. Zhejiang Zhong Yi Yao Da Xue Xue Bao 2008: 02.
13. Force* TADT. Acute respiratory distress syndrome: the berlin definition. JAMA 2012; 307: 2526-33.
14. Zheng X. Guiding principle of clinical research on new drugs of Traditional Chinese Medicine. Beijing: Medic-Pharmaceutical Sciences and Technology Publishing House, 2002: 143.
15. Tagami T, Matsui H, Horiguchi H, Fushimi K, Yasunaga H. Antithrombin and mortality in severe pneumonia patients with sepsis‐associated disseminated intravascular coagulation: an observational nationwide study. J Thromb Haemost 2014; 12: 1470-9.
16. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801-10.
17. Lu S, Zhao P, Zhao L, Dong W, Xue H, Yang C. Influence of dachengqi decoction adjuvant therapy on pH, PaO2/FiO2 and oxidative stress status of patients with ARDS. Xian Dai Sheng Wu Yi Xue Jin Zhan 2017; 17: 5501-4.
18. Jiang T, Gao B, Zhou L, et al. Clinical efficacy of Jiawei Xuanbai Chengqi Tang on patients with mechanical ventilation in ARDS. Zhong Guo Shi Yan Fang Ji Xue Za Zhi 2013; 19: 300-3.
19. Wang ZC, Xue P, Huang ZW. Effect of an early application of Chaiqin Chengqi decoction in treating severe acute pancreatitis complicated with acute respiratory distress syndrome. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2009; 29: 322-4.
20. Su YJ, Hu R, Li YH, et al. Clinical observation of baofei jiejing mixture in the treatment of mild acute respiratory distress syndrome induced by sepsis. Xian Dai Zhong Xi Yi Jie He Za Zhi 2018; 27: 685-8.
21. Liang X, Luo C, Li Y, et al. Study on intervention mechanism of Yiqi Huayu Jiedu decoction on ARDS based on network pharmacology. Evid-Based Compl Alt 2020; 2020: 4782470.
22. Lu X, Ma W, Fan B, et al, Integrating network pharmacology, transcriptome and artificial intelligence for investigating into the effect and mechanism of Ning Fei Ping Xue decoction against the acute respiratory distress syndrome. Front Pharmacol 2021; 12: 731377.
23. Liu J, Chen Q, Liu S, Yang X, Zhang Y, Huang F. Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis. Life Sci 2018; 208: 139-48.
24. Deng G, He H, Chen Z, et al. Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway. Biomed Pharmacothe 2017; 96: 148-52.
25. Ruan Y, Fan Y, Xie Y, et al. Modified xiaoqinglong decoction alleviates lipopolysaccharide-induced acute lung injury in mice by regulating arachidonic acid metabolism and exerting anti-apoptotic and anti-inflammatory effects. Anat Rec (Hoboken) 2022; 305: 1672-81.
26. Zhao J, Chen J, Tang W, Wan L, Xiong W, Zhou L. Effect of Da-cheng-qi decoction on pancreatitis-associated lung injury in patients and anti-inflammatory responses in rat models. Pharm Biol 2011; 49: 1058-64.
27. Li MJ, Ji YM, Guo L, et al. Cai wanru’s experience in treating acute lung injury. Zhejiang Zhong Yi Yao Da Xue Xue Bao 2019; 43: 959-61.
Options
Outlines

/

〈 〉